is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.^[18][19][20] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain.^{[21][22][23][12][13][14]} Es es vendido bajo la marca nombres ^[12][13][14]

Semaglutide is a glucagon-like peptide-1 receptor agonist.^{[12][13][14][12][15][16][17][24]}

It was approved for medical use in the US in 2017.^[12][25] In 2021, it was the 90th most commonly prescribed medication in the United States, with more than 8 million prescriptions